Aljas, Cherry Lyn S.
HRN: 21-96-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CEFUROXIME 1.5GM (VIAL)
09/02/2024
09/03/2024
IVT
1.5grams
Prior OR
For LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes